BRPI0512948A - biomarcadores de mal de alzheimer - Google Patents
biomarcadores de mal de alzheimerInfo
- Publication number
- BRPI0512948A BRPI0512948A BRPI0512948-6A BRPI0512948A BRPI0512948A BR PI0512948 A BRPI0512948 A BR PI0512948A BR PI0512948 A BRPI0512948 A BR PI0512948A BR PI0512948 A BRPI0512948 A BR PI0512948A
- Authority
- BR
- Brazil
- Prior art keywords
- alzheimer
- disease
- biomarkers
- test
- diagnosing
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 4
- 239000000090 biomarker Substances 0.000 title abstract 2
- 102000002254 Glycogen Synthase Kinase 3 Human genes 0.000 abstract 1
- 108010014905 Glycogen Synthase Kinase 3 Proteins 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000027061 mild cognitive impairment Diseases 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0414894.6A GB0414894D0 (en) | 2004-07-02 | 2004-07-02 | Biomarkers of alzheimer's disease |
| PCT/GB2005/002592 WO2006003414A2 (en) | 2004-07-02 | 2005-07-01 | Biomarkers of alzheimer's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0512948A true BRPI0512948A (pt) | 2008-04-15 |
Family
ID=32843494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0512948-6A BRPI0512948A (pt) | 2004-07-02 | 2005-07-01 | biomarcadores de mal de alzheimer |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20080076140A1 (https=) |
| EP (1) | EP1763674A2 (https=) |
| JP (1) | JP2008504551A (https=) |
| CN (1) | CN101010589A (https=) |
| AU (1) | AU2005258926A1 (https=) |
| BR (1) | BRPI0512948A (https=) |
| CA (1) | CA2571692A1 (https=) |
| GB (1) | GB0414894D0 (https=) |
| WO (1) | WO2006003414A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8226927B2 (en) | 2006-05-25 | 2012-07-24 | Farhad Karimi | 11C/18F-labeled inhibitors of glycogen synthase kinase-3 |
| WO2009074331A2 (en) * | 2007-12-11 | 2009-06-18 | Julius-Maximilians-Universität Würzburg | Early and differential diagnosis test for alzheimer's disease |
| WO2009114945A1 (en) | 2008-03-21 | 2009-09-24 | Neuman Manuela G | Methods and kits for the differential diagnosis of alzheimer's disease versus frontotemporal dementia, and for the diagnosis of frontotemporal dementia, comprising fas-l and ckl 18 as biomarkers |
| US20100151457A1 (en) * | 2008-12-17 | 2010-06-17 | National Tsing Hua University | Detection of Unhealthy Cell and Uses Thereof |
| US20120040361A1 (en) * | 2010-07-22 | 2012-02-16 | National Tsing Hua University | Methods and compositions for detection of lethal system and uses thereof |
| CN104237526B (zh) * | 2013-06-18 | 2016-08-17 | 磁量生技股份有限公司 | 一种检测阿兹海默症罹患风险的系统 |
| CA2941650A1 (en) * | 2014-03-05 | 2015-09-11 | Humanetics Corporation | Predicting and reducing cognitive decline based on gsk-3 levels |
| CN104698188A (zh) * | 2015-03-04 | 2015-06-10 | 华中科技大学 | 检测人血小板GSK-3β蛋白活性的斑点印迹方法 |
| CN111323597A (zh) * | 2018-12-14 | 2020-06-23 | 陈志成 | 用于检测受试者中mci和/或ad的方法、试剂盒及筛选化合物的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090041862A1 (en) * | 2004-05-07 | 2009-02-12 | Peter Robert Schofield | Detecting disease association with aberrant glycogen synthase kinase 3beta expression |
-
2004
- 2004-07-02 GB GBGB0414894.6A patent/GB0414894D0/en not_active Ceased
-
2005
- 2005-07-01 AU AU2005258926A patent/AU2005258926A1/en not_active Abandoned
- 2005-07-01 US US11/630,769 patent/US20080076140A1/en not_active Abandoned
- 2005-07-01 CA CA002571692A patent/CA2571692A1/en not_active Abandoned
- 2005-07-01 JP JP2007518700A patent/JP2008504551A/ja not_active Withdrawn
- 2005-07-01 WO PCT/GB2005/002592 patent/WO2006003414A2/en not_active Ceased
- 2005-07-01 BR BRPI0512948-6A patent/BRPI0512948A/pt not_active Application Discontinuation
- 2005-07-01 CN CNA2005800225150A patent/CN101010589A/zh active Pending
- 2005-07-01 EP EP05756942A patent/EP1763674A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2571692A1 (en) | 2006-01-12 |
| CN101010589A (zh) | 2007-08-01 |
| EP1763674A2 (en) | 2007-03-21 |
| JP2008504551A (ja) | 2008-02-14 |
| AU2005258926A1 (en) | 2006-01-12 |
| US20080076140A1 (en) | 2008-03-27 |
| WO2006003414A2 (en) | 2006-01-12 |
| GB0414894D0 (en) | 2004-08-04 |
| WO2006003414A3 (en) | 2006-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0206604A (pt) | Dispositivo de lanceta que tem ação capilar | |
| ITRM20030386A0 (it) | Metodo e test diagnostici basati sull'analisi citofluorimetrica dei linfociti t antigene-specifici. | |
| WO2003075745A3 (en) | Detection, diagnosis, and monitoring of a medical condition or disease with artificial olfactometry | |
| EP1718334A4 (en) | METHOD FOR DIAGNOSIS AND TREATMENT OF PREECLAMPSY OR ECLAMPSY | |
| WO2005034008A3 (en) | A method of anonymous medical testing and providing the patient with the test results | |
| EP2287617A3 (en) | Method for diagnosing neuro-degenerative disease | |
| WO2005052592A3 (en) | Methods for diagnosis, stratification, and monitoring of alzheimer’s disease | |
| BRPI0720035A2 (pt) | métodos para tratar um paciente tendo uma doença ou distúrbio, para tratar um paciente com doença autoimune, para neutralizar um perfil de expressão do marcador pd indutível por ifn do tipo 1 ou ifnalfa em um paciente, para monitorar ou prognosticar progressão de doença autoimune de um paciente, para monitorar a progressão da doença de um paciente que recebe o tratamento com um agente terapêutico que liga-se a e modula a atividade de ifnalfa, para identificar um paciente como um candidato para um agente terapêutico que liga-se a e modula a atividade de ifnalfa, para diagnosticar um paciente como tendo um distùrbio associado com níveis aumentados de ifnalfa, para identificar um terapêutico candidato para o tratamento de distùrbios mediados por ifnalfa e para detectar atividade de ifn em uma amostra, conjunto de sondas, e, kit | |
| EP1839056A4 (en) | Preeclampsia-DIAGNOSIS | |
| EP2520935A3 (en) | Organ-specific proteins and methods of their use | |
| MX2009004463A (es) | Ensayo para anticuerpos de troponina cardiaca. | |
| ATE411525T1 (de) | Nachweis einer histonmodifikation in zellfreien nukleosomen | |
| EE05675B1 (et) | Meetod konformse haiguse diagnoosimiseks v?i tuvastamiseks, selleks vajalik katsemenetlus, reaktiivikomplekt ning seade | |
| WO2006073682A3 (en) | Diagnostic test | |
| ATE406578T1 (de) | Candida-nachweis | |
| BR0317394A (pt) | Uso de nicotinamida n-metiltransferase como um marcador para câncer colorretal | |
| BRPI0512948A (pt) | biomarcadores de mal de alzheimer | |
| WO2008080030A3 (en) | Cardiovascular autoimmune disease panel and methods of using same | |
| EP1745739A3 (en) | Optical imaging of rheumatoid arthritis | |
| WO2007030949A3 (en) | Methods of diagnosing ovarian cancer and kits therefor | |
| ATE415632T1 (de) | Verfahren zur diagnose und behandlung von morbus crohn | |
| ATE494556T1 (de) | Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1 | |
| EP2071338A3 (en) | Human diabetes-mediating proteins | |
| MX2010002009A (es) | Panel de salud de aparato reproductor masculino y usos del mismo. | |
| WO2007015113A3 (en) | New protein isoforms of the pif-family and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |